Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
Indonesia and Toyota Explore $300M Bioethanol Investment to Boost Renewable Energy Goals 
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 
Want to cut your energy bills? Here’s how five experts are doing it 
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal 
JAPEX Shares Drop as Middle East Tensions Drive LNG Costs and Production Risks 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Rising Jet Fuel Costs from Iran Conflict Push Airfare Higher Across Europe 
OPmobility Reports Q1 Revenue Dip Amid Automotive Industry Slowdown 
Ethiopian Airlines Expands Fleet with New Boeing 787 Dreamliner Order to Boost Global Routes 
GAITHERSBURG, Md., May 25, 2017 -- OpGen, Inc. (NASDAQ:OPGN) today announced that data on its Acuitas® Rapid Test in development and Acuitas Whole Genome Sequence Analysis will be presented at ASM Microbe 2017 being held June 1-5, 2017 in New Orleans, LA. These data will demonstrate the company’s ability to predict phenotypic resistance across antibiotic classes for Gram-negative infections using rapid genetic testing and predictive algorithms from its Acuitas Lighthouse® Knowledgebase. It will also showcase advances in being able to discriminate bacterial strains using more genes to solve current limitations with conventional strain typing methods.
The details for the poster presentations at ASM Microbe are as follows:
Session info: 186 - AAID01 - Antibacterial Resistance: Genomics and New Methodologies to Trace Antimicrobial Resistance
Poster title: Predicting Antibiotic Resistance in Gram-Negative Bacilli by Rapid Detection of Resistance Genes (#87)
Presenter: Terry Walker, Ph.D.
Date and time: Saturday, June 3, 12:15 – 2:15 PM CEDT
Location: Exhibit Hall D, Exhibit and Poster Hall
Session info: 186 - AAID01 - Antibacterial Resistance: Genomics and New Methodologies to Trace Antimicrobial Resistance
Poster title: Core Genome Multilocus Sequence Typing Scheme for High-Resolution Typing of Escherichia coli (#72)
Presenter: Weizhong Chang, Ph.D.
Date and time: Saturday, June 3, 12:15 – 2:15 PM CEDT
Location: Exhibit Hall D, Exhibit and Poster Hall
About OpGen
OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. Learn more at www.opgen.com and follow OpGen on Twitter and LinkedIn.
OpGen®, Acuitas®, Acuitas Lighthouse® and QuickFISH® are registered trademarks of OpGen, Inc.
OpGen Contact: Michael Farmer Director, Marketing 240-813-1284 [email protected] [email protected] Investor and Media Contact: Cammy Duong MacDougall Biomedical Communications 781-591-3443 [email protected]
